1pf8

File:1pf8.gif

spinqualitylabelsall models 1pf8, resolution 2.51Å Show:Asymmetric Unit Biological Assembly Drag the structure with the mouse to rotate   Export Animated Image

Crystal Structure of Human Cyclin-Dependent Kinase 2 Complexed with a Nucleoside Inhibitor

OverviewOverview

SU9516 is a 3-substituted indolinone compound with demonstrated potent and, selective inhibition toward cyclin dependent kinases (cdks). Here, we, describe the kinetic characterization of this inhibition with respect to, cdk2, 1, and 4, along with the crystal structure in complex with cdk2. The, molecule is competitive with respect to ATP for cdk2/cyclin A, with a K(i), value of 0.031 microM. Similarly, SU9516 inhibits cdk2/cyclin E and, cdk1/cyclin B1 in an ATP-competitive manner, although at a 2- to 8-fold, reduced potency. In contrast, the compound exhibited non-competitive, inhibition with respect to ATP toward cdk4/cyclin D1, with a 45-fold, reduced potency. The X-ray crystal structure of SU9516 bound to cdk2, revealed interactions between the molecule and Leu83 and Glu81 of the, kinase. This study should aid in the development of more potent and, selective cdk inhibitors for potential therapeutic agents.

About this StructureAbout this Structure

1PF8 is a Single protein structure of sequence from Homo sapiens with SU9 as ligand. Active as Non-specific serine/threonine protein kinase, with EC number 2.7.11.1 Full crystallographic information is available from OCA.

ReferenceReference

SU9516: biochemical analysis of cdk inhibition and crystal structure in complex with cdk2., Moshinsky DJ, Bellamacina CR, Boisvert DC, Huang P, Hui T, Jancarik J, Kim SH, Rice AG, Biochem Biophys Res Commun. 2003 Oct 24;310(3):1026-31. PMID:14550307

Page seeded by OCA on Mon Nov 12 18:42:55 2007